Ando Tadasuke, Yamashiro Tetsu, Takita-Sonoda Yoshiko, Mannen Kazuaki, Nishizono Akira
Department of Infectious Diseases, Faculty of Medicine, Oita University, Oita, Japan.
Microbiol Immunol. 2005;49(4):311-22. doi: 10.1111/j.1348-0421.2005.tb03735.x.
A combinatorial human Fab library was constructed using RNAs from peripheral blood lymphocytes of 6 rabies vaccine-boosted volunteers using pComb3X phagemid vector. The size of the constructed library was approximately 7.0 x 10(7) Escherichia coli transformants. The library was selected against purified rabies virus (RV) virion or purified RV glycoprotein for isolation of phages displaying RVneutralizing human Fab antibody. Among 132 selected clones, two Fab preparations revealed neutralizing activities against RV strain CVS when assayed in the rapid fluorescent focus inhibition test (RFFIT). The Fab preparation EP5G3 exhibited neutralizing activity with an infected cell count reduction of 76% at a dilution of 1: 2, and of 20% at a dilution of 1: 4. The Fab preparation GD2D12 also exhibited neutralizing activity with a 57% reduction at 1: 2 and 41% reduction at 1: 4. In the co-immunoprecipitation using strain CVS, the RV glycoprotein was precipitated in reactions with both Fab preparations. The RV neutralizing ability of the Fab preparations described in the study were not directly correlated with their binding specificity for RV antigens detected by ELISA.
利用pComb3X噬菌粒载体,从6名接种狂犬病疫苗后的志愿者外周血淋巴细胞中提取RNA,构建了一个组合人Fab文库。构建文库的大小约为7.0×10⁷个大肠杆菌转化子。针对纯化的狂犬病病毒(RV)病毒粒子或纯化的RV糖蛋白对文库进行筛选,以分离展示RV中和性人Fab抗体的噬菌体。在132个筛选出的克隆中,两种Fab制剂在快速荧光灶抑制试验(RFFIT)中检测时,显示出对RV毒株CVS的中和活性。Fab制剂EP5G3在1:2稀释时感染细胞数减少76%,在1:4稀释时减少20%,表现出中和活性。Fab制剂GD2D12在1:2时减少57%,在1:4时减少41%,也表现出中和活性。在使用CVS毒株进行的共免疫沉淀中,两种Fab制剂的反应均使RV糖蛋白沉淀。该研究中描述的Fab制剂的RV中和能力与其通过ELISA检测的对RV抗原的结合特异性没有直接相关性。